<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2025-11-14 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2025-11-14/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2025-11-14"><meta property="og:description" content="ğŸ“… Daily Report - 2025-11-14 ä»Šæ—¥ç­›é€‰å‡º 84 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2025-11-14T00:00:00+00:00"><meta property="article:modified_time" content="2025-11-14T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week462025"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2025-11-14"><meta itemprop=description content="ğŸ“… Daily Report - 2025-11-14 ä»Šæ—¥ç­›é€‰å‡º 84 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><meta itemprop=datePublished content="2025-11-14T00:00:00+00:00"><meta itemprop=dateModified content="2025-11-14T00:00:00+00:00"><meta itemprop=wordCount content="2505"><meta itemprop=keywords content="Research,Daily,Week462025"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2025-11-14"><meta name=twitter:description content="ğŸ“… Daily Report - 2025-11-14 ä»Šæ—¥ç­›é€‰å‡º 84 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-14</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2025-11-14T00:00:00Z>2025-11-14</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</a></li><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2025-11-14>ğŸ“… Daily Report - 2025-11-14</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>84</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>4</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
é¦–æ¬¡å‘ç°ç™Œç»†èƒåˆ©ç”¨â€œç—›æ„Ÿç¥ç»â€è¿œç¨‹æ“æ§å…ç–«ç³»ç»Ÿï¼Œé˜»æ–­æ­¤é€šè·¯å¯å®ç°æŠ—ç™Œä¸é•‡ç—›â€œåŒèµ¢â€ï¼›AIæŠ€æœ¯åœ¨å•ç»†èƒæ•°æ®è§£é‡Šæ–¹é¢å–å¾—çªç ´æ€§è¿›å±•ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒè°ƒæ§</strong>ï¼šè¯†åˆ«å¹¶é¶å‘ç‰¹å®šç»†èƒäºšå‹ï¼ˆå¦‚HLA-DR+è‚¿ç˜¤ç»†èƒã€PLAUR+ä¸­æ€§ç²’ç»†èƒã€CD177+ä¸­æ€§ç²’ç»†èƒã€CTCF+TANã€IL-33+å†…çš®ç»†èƒã€MMP11+æˆçº¤ç»´ç»†èƒï¼‰ä»¥æ”¹å–„å…ç–«æ²»ç–—ç–—æ•ˆæˆ–å‡è½»ç–¾ç—…æŸä¼¤ã€‚</li><li><strong>è‚ é“-è‚è„è½´ä¸ä»£è°¢è°ƒæ§</strong>ï¼šè§£æè‚ é“-è‚è„è½´çš„ä»£è°¢è°ƒæ§æœºåˆ¶ï¼Œä»¥åŠä»£è°¢ç‰©å¯¹å·¨å™¬ç»†èƒæåŒ–å’Œè‚¿ç˜¤çš„å½±å“ã€‚</li><li><strong>å•ç»†èƒä¸ç©ºé—´ç»„å­¦åº”ç”¨</strong>ï¼šæ¢ç´¢å•ç»†èƒç©ºé—´è½¬å½•ç»„å­¦åœ¨è„‘å’Œè‚ºç ”ç©¶ä¸­çš„å¹³å°æ¯”è¾ƒï¼›ç©ºé—´ä¸‰ç»„å­¦ç»˜åˆ¶å¤§è„‘å‘è‚²ä¸ç¥ç»ç‚ç—‡å›¾è°±ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>å¤šç»„å­¦ç»“åˆ</strong>ï¼šè¿ç”¨å•ç»†èƒã€ç©ºé—´ç»„å­¦ã€å¹²æ¹¿ç»“åˆã€æœºå™¨å­¦ä¹ ç­‰å¤šç§æŠ€æœ¯æ‰‹æ®µè¿›è¡Œæ·±åº¦åˆ†æã€‚</li><li><strong>AIè¾…åŠ©åˆ†æ</strong>ï¼šAIæŠ€æœ¯åœ¨å•ç»†èƒæ•°æ®è§£é‡Šæ–¹é¢å±•ç°å‡ºå·¨å¤§æ½œåŠ›ã€‚</li></ul><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
CDK4/6æŠ‘åˆ¶å‰‚åœ¨ä¹³è…ºç™Œæ²»ç–—ä¸­å±•ç°å‡ºé‡å¡‘å…ç–«è‚½æ®µç»„ã€è¯±å¯¼æŒä¹…ç”Ÿé•¿åœæ»çš„æ½œåŠ›ï¼›åŒæ—¶ï¼ŒKRASå’ŒCDK4çš„è”åˆé¶å‘æ²»ç–—åœ¨èƒ°è…ºç™Œä¸­æ˜¾ç¤ºå‡ºååŒæ•ˆåº”ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>ç™Œç—‡å…ç–«é€ƒé€¸æœºåˆ¶ï¼šå¦‚6PGDæŠ‘åˆ¶ä¸å¤©ç„¶å…ç–«åº”ç­”çš„å…³è”ï¼Œä»¥åŠPD-L1å’ŒmiR-27a-3pååŒé‡å¡‘Tç»†èƒæ²»ç–—ç‚ç—‡æ€§è‚ ç—…ã€‚</li><li>ä¿¡å·é€šè·¯ä¸è€è¯æ€§ï¼šOxr1å¤±è°ƒåœ¨æ…¢æ€§é«“ç³»ç™½è¡€ç—…TKIè€è¯ä¸­çš„ä½œç”¨ï¼›USP13ç¨³å®šSOX9ä¿ƒè¿›è„‚è‚ªè‚åŠè‚ç™Œå¹²ç»†èƒè¡¨å‹ã€‚</li><li>è¡¨è§‚é—ä¼ è°ƒæ§ï¼šDNAç”²åŸºåŒ–ç¼–è¾‘åœ¨ä½“å†…ç ”ç©¶ï¼›Sp8å’ŒBrachyuryåœ¨èƒšèƒå¹²ç»†èƒåˆ†åŒ–ä¸­çš„ç»“åˆè°±ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>æ•´åˆå¤šç»„å­¦æ•°æ®ï¼ˆå…¨å¤–æ˜¾å­ç»„æµ‹åº+scRNA-seqï¼‰æ­ç¤ºç‰¹å®šç™Œç—‡æ ·æœ¬ç‰¹å¾ã€‚</li><li>ç©ºé—´è½¬å½•ç»„å­¦åˆ†æè¡°è€åµå·¢ã€‚</li></ul><h3 id=-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
æ­ç¤ºäº†ä¼‘çœ ç™Œç»†èƒï¼ˆDCCï¼‰çš„æœºåˆ¶ï¼Œä¸ºå…‹æœç™Œç—‡è½¬ç§»å’Œæ²»ç–—è€è¯æ€§æä¾›äº†æ–°è§†è§’ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>æ¢ç´¢Tetraspanin 13ï¼ˆTSPAN13ï¼‰åœ¨ä¹³è…ºç™Œå…ç–«é€ƒé€¸ä¸­çš„ä½œç”¨ï¼ŒåŠå…¶é€šè¿‡MHC-Ié™è§£å¢å¼ºå…ç–«æŠ‘åˆ¶çš„æœºåˆ¶ã€‚</li><li>ç ”ç©¶TET2å¤±æ´»åœ¨é€ è¡€ç³»ç»Ÿä¸­çš„ä½œç”¨ï¼Œä»¥åŠå…¶å¦‚ä½•å¢å¼ºå…ç–«æ£€æŸ¥ç‚¹é˜»æ–­ï¼ˆICBï¼‰çš„ç–—æ•ˆã€‚</li><li>å…³æ³¨EGFRçªå˜éå°ç»†èƒè‚ºç™Œï¼ˆNSCLCï¼‰ä¸­EGFR TKIè€è¯çš„æœºåˆ¶åŠæ–°å‹æ²»ç–—ç­–ç•¥ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>æ•´åˆåŸºå› ç»„ã€è¡¨å‹å’Œæ´»ç»†èƒæˆåƒåˆ†æï¼Œç”¨äºè§£ç ç™Œç—‡ä¼‘çœ ã€‚</li><li>åŠ¨æ€è‚¿ç˜¤å…ç–«è¡¨å‹åˆ†æï¼Œè¯„ä¼°æ–°è¾…åŠ©åŒ–ç–—è”åˆæ›²å¦¥ç å•æŠ—æ²»ç–—HER2é˜³æ€§ä¹³è…ºç™Œçš„ç–—æ•ˆã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
AIé©±åŠ¨çš„å¤šæ¨¡æ€å­¦ä¹ å·¥å…·CellWhispererå®ç°åŸºäºè‡ªç„¶è¯­è¨€çš„å•ç»†èƒåŸºå› è¡¨è¾¾æ•°æ®äº¤äº’æ¢ç´¢ï¼Œé©æ–°ç”Ÿç‰©æ•°æ®åˆ†ææ–¹å¼ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>åˆ©ç”¨AIå’ŒRNAæµ‹åºæ•°æ®ï¼Œå®ç°å•ç»†èƒåŸºå› è¡¨è¾¾çš„è‡ªç„¶è¯­è¨€äº¤äº’å¼æ¢ç´¢ã€‚</li><li>æ•´åˆåŠŸèƒ½æ€§è¯ç‰©æµ‹è¯•ã€RNAæµ‹åºä¸AIï¼Œä¸ºç™Œç—‡æ‚£è€…æä¾›ä¸ªæ€§åŒ–æ²»ç–—æ´å¯Ÿã€‚</li><li>GLP-1ç±»è¯ç‰©ï¼ˆå¦‚Ozempicã€Wegovyï¼‰å¯èƒ½æ˜¾è‘—é™ä½ç»“ç›´è‚ ç™Œæ‚£è€…æ­»äº¡ç‡ã€‚</li><li>å¼€å‘æ–°å‹æ™ºèƒ½è¯ç‰©ï¼Œé¶å‘å¹¶ç ´åç™Œç»†èƒä¾èµ–çš„ç‰¹å®šRNAç»“æ„ï¼Œè§¦å‘ç»†èƒè‡ªæ¯ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>åŸºäºAIçš„å¤šæ¨¡æ€å­¦ä¹ ï¼Œå®ç°ç”Ÿç‰©æ•°æ®ï¼ˆRNAæµ‹åºï¼‰ä¸è‡ªç„¶è¯­è¨€çš„èåˆã€‚</li><li>æ™ºèƒ½è¯ç‰©è®¾è®¡ï¼Œèƒ½è¯†åˆ«å¹¶ä½œç”¨äºRNAçš„ç‰¹å®šæŠ˜å ç»“æ„ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ“° å…¬ä¼—å· (38æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>Early View | å—æ–¹åŒ»ç§‘å¤§å­¦ä½™å…‰åˆ›æ•™æˆå›¢é˜Ÿ ä¸¤ç§æµ‹åºå¹³å°åœ¨å°é¼ è„‘å’Œè‚ºå•ç»†èƒç©ºé—´è½¬å½•ç»„å­¦ç ”ç©¶ä¸­çš„æ¯”è¾ƒ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šYuLabSMU</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šæµ‹åºã€å•ç»†èƒã€ç©ºé—´è½¬å½•ç»„ã€ç©ºé—´ç»„å­¦ã€è½¬å½•ç»„</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šEarly View | å—æ–¹åŒ»ç§‘å¤§å­¦ä½™å…‰åˆ›æ•™æˆå›¢é˜Ÿ Illumina NovaSeq 6000 ä¸ GeneMind SURFSeq 5000å¹³å°åœ¨å°é¼ è„‘å’Œè‚ºå•ç»†èƒç©ºé—´è½¬å½•ç»„å­¦ç ”ç©¶ä¸­çš„æ¯”è¾ƒ</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI5NjUyNzkxMg==&amp;mid=2247498252&amp;idx=1&amp;sn=1aa97994684c25c7ae3e4231a8033760">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>æœ€æ–°14+ç”Ÿä¿¡ï¼Œé€šè¿‡å•ç»†èƒåˆ†æè¯†åˆ«HLA-DR +è‚¿ç˜¤ç»†èƒï¼Œå¹¶åˆ†æå…¶å¯¹ CD8+T ç»†èƒåŠé¢„åçš„å½±å“ï¼Œæ€è·¯æ–°é¢–ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å•ç»†èƒã€ç”Ÿä¿¡ã€é€šè·¯</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503959&amp;idx=7&amp;sn=258dd76f48cf11330258c9f0cf0a7c5b">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>æœ€æ–°14+ç”Ÿä¿¡ï¼Œå•ç»†èƒè¯†åˆ«PLAUR+ä¸­æ€§ç²’ç»†èƒå¡‘é€ å…ç–«æŠ‘åˆ¶å¾®ç¯å¢ƒï¼ŒæŠ‘åˆ¶PLAUR å¢å¼ºæŠ— PD1 ç–—æ•ˆã€‚é«˜åˆ†æ–‡ç« ç»å…¸æ€è·¯ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€å…ç–«å¾®ç¯å¢ƒã€å•ç»†èƒã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503959&amp;idx=5&amp;sn=ced8641c095eceaa9678fa06d1bf8ef4">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>10.6åˆ†éè‚¿ç˜¤å¹²æ¹¿ç»“åˆç”Ÿä¿¡ï¼Œé¶å‘ CD177 + ä¸­æ€§ç²’ç»†èƒå‡è½»ç¼ºè¡€å†çŒæ³¨æŸä¼¤ã€‚é€‚åˆåŠ¨ç‰©å»ºæ¨¡æµ‹åºæ€è·¯ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€æµ‹åºã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503959&amp;idx=6&amp;sn=c75c9951e60626368294935ff46af274">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>æœ€æ–°10åˆ†ç”Ÿä¿¡ï¼Œå•ç»†èƒ+ç©ºè½¬å¤šç»„å­¦è¿›è¡Œä¸­æ€§ç²’ç»†èƒäºšå‹åˆ†æï¼Œè¯†åˆ« CTCF+TANï¼Œé¶å‘CTCFæ”¹å–„å…ç–«æ²»ç–—ç–—æ•ˆï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€å•ç»†èƒã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503959&amp;idx=1&amp;sn=98fdaa5daa63ceef5f7ad03d9d1e3575">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>ã€ŠCellã€‹ï¼šç™Œç»†èƒç«Ÿç”¨â€œç—›æ„Ÿç¥ç»â€è¿œç¨‹æ“æ§å…ç–«ç³»ç»Ÿï¼é˜»æ–­æ­¤é€šè·¯ï¼Œå¯å®ç°æŠ—ç™Œä¸é•‡ç—›â€œåŒèµ¢â€</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡äºº</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€ç¥ç»ã€é€šè·¯</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šåœ¨è‚¿ç˜¤å…ç–«å­¦é¢†åŸŸï¼Œä¸ºä»€ä¹ˆå¼ºå¤§çš„å…ç–«ç³»ç»Ÿä¼šâ€œå¤±çµâ€ï¼Œä»»ç”±ç™Œç»†èƒç”Ÿé•¿ï¼Ÿ</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248461&amp;idx=1&amp;sn=1a190d284eabc1102646736924ac7090">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>æœ€æ–°7.5åˆ†ç”Ÿä¿¡ï¼Œå¤šç»„å­¦ç»“åˆæœºå™¨å­¦ä¹ ç­›é€‰è‚¥èƒ–ç›¸å…³çš„å…³é”®åŸºå› å¹¶éªŒè¯ï¼Œéè‚¿ç˜¤ç»å…¸æ€è·¯ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šä¸œæ™“ç”Ÿç‰©</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç”Ÿä¿¡</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&amp;mid=2247493008&amp;idx=1&amp;sn=18b8c9c83e0a9a10bad5e6735e65a7e1">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>åŸºå› æ³¨é‡Šä¿¡æ¯æ•´åˆæœ‰å›°éš¾ï¼Ÿæ‰¾GenomicFeaturesåŒ…å¸®ä½ æå®šæ‰€æœ‰åŸºå› ç»„æ³¨é‡Šéš¾é¢˜ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šäº‘ç”Ÿä¿¡</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šåŸºå› ç»„ã€RåŒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg5MDk3Mzg4OA==&amp;mid=2247498469&amp;idx=1&amp;sn=00dfdccbc88ce612a1d523e7dbe87f38">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>åˆšåˆšå‘è¡¨çš„8.9åˆ†ç”Ÿä¿¡ï¼Œé™¤äº†è¯†åˆ«æŸåŸºå› é˜³æ€§ç»†èƒï¼Œè¯†åˆ«æŸé€šè·¯/è¡¨å‹é˜³æ€§ç»†èƒä¹Ÿæ˜¯å‘æ–‡çš„å¥½æ€è·¯ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç”Ÿä¿¡ã€é€šè·¯</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503959&amp;idx=3&amp;sn=a1374a34ca21fd2bdd5248cfdac4e615">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>33+ç”Ÿä¿¡ï¼Œ è¯†åˆ«ä»ç™Œå‰ç—…å˜åˆ°è‚¿ç˜¤ä¸åŒæ¶æ€§ç¨‹åº¦ç›¸å…³çš„ç»†èƒäºšå‹ï¼Œé’ˆå¯¹IL-33+å†…çš®ç»†èƒä¿ƒè¿›ç–¾ç—…è¿›å±•è¿›è¡Œå®éªŒéªŒè¯ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503959&amp;idx=2&amp;sn=72e4d892b554597196b8b15bac2eeebb">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 28 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E5%85%AC%E4%BC%97%E5%8F%B7>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (35æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡-1>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE278674 é˜»æ–­ 6PGD å¯é™åˆ¶ç™Œç—‡ä¸­ç”±å…ˆå¤©å…ç–«ååº”é©±åŠ¨çš„å…ç–«æŠ‘åˆ¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€regex:immuno(logy|therapy|suppression)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Saeed Daneshmandi ; Eduardo C Gomez ; Jianmin Wang ; Hemn MohammadpourSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe pentose phosphate pathway (PPP) has always been relegated to the background of cellular metabolism, but our research identifies its unique and provocative influence on cell function, specifically in myeloid-derived suppressor cells (MDSCs). Weâ€™ve uncovered that 6-phosphogluconate dehydrogenase (6PGD), a rate limiting enzyme in this pathway, is not just a metabolic enzyme but a crucial determinant of MDSC behavior. While the IL-6/STAT3 axis propels 6PGD activity, it also empowers MDSCs to exert their immune-suppressive prowess. When we disrupt 6PGD â€“ either through genetic knockout or pharmacological inhibition â€“ an astonishing transformation occurs. The accumulation of 6-phosphogluconate (6PG) sets off a cascade involving JNK1-IRS-1 interaction and PI3K-AKT-pDRP1 signaling pathway, triggering mitochondrial fragmentation and dismantling oxidative phosphorylation (OXPHOS). This change in metabolism doesnâ€™t just disrupt MDSC function; it transforms it stimulatory, leading to a strong anti-tumor response and making anti-PD1 therapies much more effective. Our results suggest we need to completely rethink the role of the PPP in cell function, with 6PGD emerging as a key target that could change the future of cancer immunotherapy.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE278674">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE254498 æ•´åˆå…¨å¤–æ˜¾å­ç»„æµ‹åºå’Œå•ç»†èƒRNAæµ‹åºæ­ç¤ºäº†VHLç—…èƒŒæ™¯ä¸‹å‘ç”Ÿçš„ä¸€ä¾‹é€æ˜ç»†èƒè‚¾ç»†èƒç™Œæ ·æœ¬çš„ç‰¹å¾</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcarcinomaã€sequencingã€scRNA</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Wenhao Lu ; Tingwei Jin ; Xiaoxiang Yu ; Yixuan Liu ; Shengzhu Huang ; Zheng Wen ; Cheng Su ; Yu Ye ; Ziyan Huang ; Zengnan Mo ; Zhenyuan YuSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensClear cell renal cell carcinoma (ccRCC) arising in the setting of von Hippelâ€“Lindau (VHL) disease is a rare type of kidney cancer and features VHL germline mutation. This type of ccRCC is rarely characterised at the single-cell level. In this work, whole-exome sequencing and single-cell RNA sequencing (scRNA-seq) were conducted on one ccRCC sample with VHL disease. Integrating scRNA-seq and whole-exome sequencing data by the Seurat package, we determined the relationship between single-cell transcriptome features and gene mutations. Immunohistochemistry and immunofluorescence were performed on one VHL germline mutation ccRCC and six non-VHL germline mutation ccRCC samples. We revealed the gene expression characteristics of ccRCC with VHL germline mutation. The frameshift mutations in OBP2A and BCR1, and the elevated expression of COX7A1 were most specific characteristics of ccRCC tumor cells with VHL mutation. And the extensive infiltration of exhausted T cells was the characteristic of tumor microenvironment. In addition, we discovered the relationship between genetic mutations and immune checkpoints. This work highlights the single-cell transcriptome and DNA-level information of this rare ccRCC and will provide more genetic insights and references into this rare disease.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE254498">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>GSE281956 æ°§åŒ–æŠµæŠ— 1 (Oxr1) å¤±è°ƒä¿ƒè¿›æ…¢æ€§ç²’ç»†èƒç™½è¡€ç—…ä¸­çš„ TKI è€è¯æ€§å’Œæ€¥å˜æœŸã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€resistance</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Genome variation profiling by high throughput sequencing ; Expression profiling by high throughput sequencing ; OtherOrganism : Homo sapiens ; Mus musculusThis SuperSeries is composed of the SubSeries listed below.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281956">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>GSE281955 æ°§åŒ–æŠµæŠ— 1 (Oxr1) å¤±è°ƒä¿ƒè¿›æ…¢æ€§ç²’ç»†èƒç™½è¡€ç—…ä¸­çš„ TKI è€è¯æ€§å’Œæ€¥å˜æœŸ [æ•°æ®é›† 3]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€resistance</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Weiqi Huang ; Elizabeth Eklund ; Priyam PatelSeries Type : OtherOrganism : Mus musculusTo unravel the intricate interplay among Oxr1, ROS-induced genetic changes, and dynamics influencing TKI resistance and CML progression</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281955">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> <strong>GSE281954 æ°§åŒ–æŠµæŠ— 1 (Oxr1) å¤±è°ƒä¿ƒè¿›æ…¢æ€§ç²’ç»†èƒç™½è¡€ç—…ä¸­çš„ TKI è€è¯æ€§å’Œæ€¥å˜æœŸ [æ•°æ®é›† 2]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€resistance</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Weiqi Huang ; Elizabeth Eklund ; Priyam PatelSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusTo unravel the intricate interplay among Oxr1, ROS-induced genetic changes, and dynamics influencing TKI resistance and CML progression</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281954">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> <strong>GSE281856 æ°§åŒ–æŠµæŠ— 1 (Oxr1) å¤±è°ƒä¿ƒè¿›æ…¢æ€§ç²’ç»†èƒç™½è¡€ç—…ä¸­çš„ TKI è€è¯æ€§å’Œæ€¥å˜æœŸ [æ•°æ®é›† 1]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€resistance</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Weiqi Huang ; Elizabeth Eklund ; Priyam PatelSeries Type : Genome variation profiling by high throughput sequencingOrganism : Mus musculusTo unravel the intricate interplay among Oxr1, ROS-induced genetic changes, and dynamics influencing TKI resistance and CML progression</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281856">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>GSE280073 ä½“å†…DNAç”²åŸºåŒ–ç¼–è¾‘[ChIP-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šChIP-seqã€methylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Richard Pan ; Luis Flores ; X Shawn LiuSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusDNA methylation is an epigenetic mechanism essential for orchestrating gene expression. Precise editing of DNA methylation has emerged as a new method to dissect its biological function in a DNA sequence specific manner with great potential to treat human diseases. However, applications of DNA methylation editing are largely in vitro. An experimental system to systematically investigate in vivo DNA methylation editing is needed to reveal its full therapeutic potential. We generated two transgenic mouse lines carrying an inducible dCas9-Dnmt3a or dCas9-Tet1 editor to enable cell-type specific methylation editing in vivo. We demonstrated that targeted methylation of the Psck9 promoter in the liver of dCas9-Dnmt3a mice reduced Psck9 expression and lowered plasma low-density lipoprotein cholesterol level to reduce the risk for cardiovascular diseases. Targeted demethylation of the Mecp2 promoter by dCas9-Tet1 reactivated Mecp2 expression from the inactive X chromosome in the brain of Mecp2 heterozygous Rett syndrome mice, suggesting a promising therapeutic approach for Rett syndrome and other X-linked diseases. Genome-wide sequencing analysis showed no detectable off-target at the transcriptional level in the methylation edited mice. These results demonstrate the feasibility and versatility of methylation editing in vivo, to explore DNA methylation in normal physiology and develop treatments for human diseases.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280073">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>GSE280072 ä½“å†…DNAç”²åŸºåŒ–ç¼–è¾‘[RNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€methylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Richard Pan ; X Shawn LiuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusDNA methylation is an epigenetic mechanism essential for orchestrating gene expression. Precise editing of DNA methylation has emerged as a new method to dissect its biological function in a DNA sequence specific manner with great potential to treat human diseases. However, applications of DNA methylation editing are largely in vitro. An experimental system to systematically investigate in vivo DNA methylation editing is needed to reveal its full therapeutic potential. We generated two transgenic mouse lines carrying an inducible dCas9-Dnmt3a or dCas9-Tet1 editor to enable cell-type specific methylation editing in vivo. We demonstrated that targeted methylation of the Psck9 promoter in the liver of dCas9-Dnmt3a mice reduced Psck9 expression and lowered plasma low-density lipoprotein cholesterol level to reduce the risk for cardiovascular diseases. Targeted demethylation of the Mecp2 promoter by dCas9-Tet1 reactivated Mecp2 expression from the inactive X chromosome in the brain of Mecp2 heterozygous Rett syndrome mice, suggesting a promising therapeutic approach for Rett syndrome and other X-linked diseases. Genome-wide sequencing analysis showed no detectable off-target at the transcriptional level in the methylation edited mice. These results demonstrate the feasibility and versatility of methylation editing in vivo, to explore DNA methylation in normal physiology and develop treatments for human diseases.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280072">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>GSE274072 USP13 ç¨³å®š SOX9 ä»¥ä¿ƒè¿›ä»£è°¢åŠŸèƒ½éšœç¢ç›¸å…³çš„è„‚è‚ªè‚ç–¾ç—…å’Œè‚ç™Œå¹²ç»†èƒè¡¨å‹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€metabolic</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Shao Na ; Zhang Lin ; Tan Xu ; Xiang Jingyi ; Xi Lei ; Idris Muhammad ; Shen Gufang ; Zhou Lu ; Ni Yuanshu ; Zhang Qiongyi ; Xu Feng ; Liu ChungangSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensDeregulation of SOX9 has been linked with metabolic diseases, self-renewal and cancer. SOX9, a master regulator of cell growth, can be regulated by a diverse set of Post-Translational Modifications (PTMs), including ubiquitylation. This study aims to elucidate the mechanisms that govern SOX9 protein stability that is mediated by the ubiquitin-proteasome system. Following a screen of the deubiquitinase library, SOX9 protein abundance was found to be regulated by ubiquitin-specific peptidase 13 (USP13) which deubiquitylates SOX9 and inhibits its protein degradation. Additionally, USP13 attenuates FBXW7- and KEAP1-mediated ubiquitination and degradation of SOX9 by directly binding to the SOX9 K2 domain, which contains a critical ubiquitination residue-K249. Genetic deletion or pharmacological inhibition of USP13 markedly decreases the metabolic dysfunction-associated fatty liver disease (MAFLD) development, the stemness capacity of liver cancer cells and enhances its chemo-sensitivity. Overexpression of exogenous SOX9 in USP13 deficient cells restored liver cancer cells self-renewal capacity and tumorigenesis. Clinical analyses revealed that the USP13-SOX9 axis is associated with poor prognosis in human hepatocellular carcinoma (HCC) patients. Therefore, pharmacological interventions targeting USP13 may have therapeutic potential for the treatment of HCC and MAFLD prevalent diseases.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274072">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>GSE267315 è¡°è€äººç±»åµå·¢çš„ç©ºé—´è½¬å½•ç»„ç‰¹å¾</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šagingã€spatial</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Meiling Zhang ; Fanghao Guo ; Qing Zhang ; Qianhui Hu ; Di Sun ; Yongjian Ma ; Yanquan Li ; Mengxi Guo ; Haixia Ding ; Ying Guo ; Baicai Yang ; Songmao Li ; Ningxia Sun ; Yuxuan Zheng ; Wen LiSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensOvarian aging is a complex process that compromises fertility and elevates the risk of reproductive disorders. To elucidate its spatiotemporal dynamics, we integrated single-nucleus RNA sequencing and spatial transcriptomics to construct a comprehensive aging atlas of 12 human ovarian tissues spanning ages 12-54. Our analysis revealed aging-associated transcriptomic shifts, including impaired mitochondrial oxidative phosphorylation and reproductive structure development in aged human ovaries. We identified a novel endothelial cell (EDC) subtype, CLDN5âº blood EDCs, which exhibited unique functional specialization as (semi-professional) antigen-presenting cells. In contrast to other cell types that lost cell identity during aging, CLDN5âº blood EDCs displayed transcriptomic sensitivity to aging, characterized by enhanced antigen-presenting capabilities, and heightened inflammatory activity. Spatial mapping further uncovered immunoglobulin-expressing cell (IGHG1+/IGKC+) accumulation in the ovarian periphery, correlating with advancing age. Critically, aging disrupted global cellular connectivity while amplifying the DLK1:NOTCH3 axis between theca cells and CLDN5âº blood EDCs, which may contribute to the dysregulation of ovarian functions. The progressively upregulation of DLK1 indicates it as a robust biomarker of ovarian aging. This study significantly enhances our comprehension of the underlying mechanisms of human ovarian aging and concurrently pinpoints potential therapeutic avenues for addressing related disorders.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE267315">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 25 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ”¬ æœŸåˆŠæ–‡ç«  (7æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨7æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨7æ¡ï¼‰</h4><p><strong>1.</strong> <strong>è€é¾„åŒ–ç™Œç—‡å¹¸å­˜è€…äººç¾¤çš„å¿ƒè¡€ç®¡é£é™©ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡ã€å¿ƒè¡€ç®¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext:</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1988635595092635648/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>è§£ç ç™Œç—‡ä¼‘çœ ï¼šæ•´åˆåŸºå› ç»„ã€è¡¨å‹å’Œæ´»ç»†èƒæˆåƒåˆ†æï¼Œæ­ç¤ºéšè—çš„ç™Œç»†èƒåº“</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡ã€åŸºå› ç»„</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: è½¬ç§»æ˜¯ç™Œç—‡æ²»ç–—ä¸­æœ€å›°éš¾çš„éšœç¢ä¹‹ä¸€ï¼Œæ˜¯è®¸å¤šç™Œç—‡ç›¸å…³æ­»äº¡çš„åŸå› ã€‚äº†è§£é©±åŠ¨ç–¾ç—…è¿›å±•çš„æœºåˆ¶å¯¹äºæ”¹å–„æ‚£è€…é¢„åå’Œåˆ¶å®šæ›´æœ‰æ•ˆçš„æ²»ç–—ç­–ç•¥è‡³å…³é‡è¦ã€‚è¿™ç§ç°è±¡ä¼¼ä¹æ˜¯ç”±ä¼‘çœ ç™Œç»†èƒ ï¼ˆDCCï¼‰ å¼•èµ·çš„ï¼Œè¿™äº›ç»†èƒå¯ä»¥é•¿æ—¶é—´æŒç»­æœªè¢«å‘ç°ï¼Œè¿›å…¥éå¢æ®–ã€å†¬çœ æ ·çŠ¶æ€ï¼Œä»è€Œå¯¹ä¼ ç»Ÿç–—æ³•äº§ç”Ÿè€è¯æ€§å¹¶ä¿ƒè¿›å…ç–«é€ƒé¿ã€‚ç”±äº DCC ä½œä¸ºç¨€æœ‰ä¸”èƒ½é‡å—é™çš„äººç¾¤ï¼ŒåŠ ä¸Šå½“å‰åŒ»å­¦æˆåƒçš„å±€é™æ€§ï¼Œå®ƒä»¬å¾€å¾€é€ƒé¿æ—©æœŸå‘ç°ï¼Œé˜»ç¢äº†åŠæ—¶å¹²é¢„å’Œæœ‰æ•ˆçš„ä¸´åºŠç®¡ç†ã€‚å› æ­¤ï¼Œè¿«åˆ‡éœ€è¦å¼€å‘é«˜åˆ†è¾¨ç‡æ£€æµ‹ç³»ç»Ÿå¹¶è¯†åˆ«ç‰¹å®šçš„ DCC é¶å‘ç”Ÿç‰©æ ‡å¿—ç‰©ã€‚åœ¨è¿™é‡Œï¼ŒæŠ¥å‘Šäº†å¯¹å½“å‰å¯¹ DCC çš„ç†è§£çš„å…¨é¢æ¦‚è¿°ï¼Œé‡ç‚¹å…³æ³¨å…¶è¯†åˆ«å’Œè·Ÿè¸ªå®éªŒç­–ç•¥çš„æœ€æ–°è¿›å±•ï¼Œä»¥åŠç›®å‰æ­£åœ¨è¿›è¡Œçš„æ—¨åœ¨é¶å‘è¿™äº›éš¾ä»¥æ‰æ‘¸çš„ç»†èƒçš„ä¸´åºŠç ”ç©¶æ–¹æ³•ã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1988844182372986880/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>æ–°è¾…åŠ©åŒ–ç–—è”åˆæ›²å¦¥ç å•æŠ—æ²»ç–— HER2 é˜³æ€§ä¹³è…ºç™Œçš„åŠ¨æ€è‚¿ç˜¤å…ç–«è¡¨å‹å‰æ™¯</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: å¯¹äº HER2 é˜³æ€§ä¹³è…ºç™Œï¼ˆBCï¼‰ï¼Œè¾¾åˆ°ç—…ç†å®Œå…¨ç¼“è§£ï¼ˆpCRï¼‰çš„æ‚£è€…é¢„è®¡å°†å…·æœ‰æ›´å¥½çš„ä¸´åºŠç»“æœã€‚éšç€æ–°è¾…åŠ©åŒ–ç–—ï¼ˆNACï¼‰è”åˆé¶å‘æ²»ç–—æ—¶ä»£çš„åˆ°æ¥ï¼ŒHER2 é˜³æ€§ BC çš„ pCR ç‡æ˜¾ç€æé«˜ï¼Œä½†å…¶ä¸­çº¦ 50%çš„æ‚£è€…ä»ç„¶å¯¹é¶å‘æ²»ç–—æ²¡æœ‰ååº”ã€‚è‚¿ç˜¤å¾®ç¯å¢ƒï¼ˆTMEï¼‰çš„åŠ¨æ€å˜åŒ–å¯èƒ½å¯¹ HER2 é˜³æ€§ BC çš„ pCR ç»“æœäº§ç”Ÿå…³é”®å½±å“ã€‚ç„¶è€Œï¼Œç›®å‰è¿˜æ²¡æœ‰ä¸æ²»ç–—æœŸé—´ç–—æ•ˆç›¸å…³çš„ç‰¹å¼‚æ€§å…ç–«è¡¨å‹ç ”ç©¶ã€‚æˆ‘ä»¬å¯¹ 28 ä¾‹ HER2 é˜³æ€§ BC æ‚£è€…è·å¾—çš„ 94 ä¸ª ROI è¿›è¡Œäº†å…¨é¢çš„ç©ºé—´è¡¨è¾¾åˆ†æï¼ŒåŒ…æ‹¬ä»–ä»¬çš„åˆå§‹è¯Šæ–­é˜¶æ®µå’Œæœ¯åçŠ¶æ€ã€‚åˆ©ç”¨ DSP æŠ€æœ¯ï¼Œæˆ‘ä»¬ç²¾ç¡®åœ°ç»˜åˆ¶å’Œé‡åŒ–äº†æ‚£è€…åœ¨è¿™äº›å…³é”®æ—¶é—´ç‚¹çš„ TMEã€‚å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œæˆ‘ä»¬å°†æ ‡æœ¬åˆ†ä¸ºå››ç»„ï¼šIM1ã€IM2ã€TM1 å’Œ TM2ã€‚ä»¥ CD4âº å¹¼ç¨š T ç»†èƒå’Œå¹¼ç¨š B ç»†èƒä¸ºç‰¹å¾çš„ IM1 å’Œ TM1 æ˜¾ç¤ºå‡ºè¾ƒé«˜çš„ pCR ç‡ï¼Œè€Œ IM2 å’Œ TM2 è¡¨ç°å‡ºè¾ƒä½çš„ç‡ã€‚æ­¤å¤–ï¼Œæœ¯åè¢«å½’ç±»ä¸º</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1988844183140544512/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>Tetraspanin 13 é€šè¿‡ä¿ƒè¿› MHC-I é™è§£å¢å¼ºä¹³è…ºç™Œçš„å…ç–«é€ƒé€¸</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ä¸é«˜å…ç–«åŸæ€§æ¶æ€§è‚¿ç˜¤ç›¸æ¯”ï¼Œä¹³è…ºç™Œé€šå¸¸å…·æœ‰â€œå†·â€è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒï¼Œå…¶ç‰¹å¾æ˜¯å…ç–«ç»†èƒæµ¸æ¶¦ä½å’Œæ•ˆåº” T ç»†èƒæ¿€æ´»æœ‰é™ã€‚è¿™ç§å…ç–«æŠ‘åˆ¶è¡¨å‹å¯¹å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚å’Œå…¶ä»–å…ç–«æ²»ç–—æ–¹æ³•çš„ç–—æ•ˆæ„æˆäº†é‡å¤§éšœç¢ï¼Œå‡¸æ˜¾äº†ç¡®å®šé™åˆ¶æŠ—è‚¿ç˜¤å…ç–«æœºåˆ¶çš„å¿…è¦æ€§ã€‚åœ¨è¿™é¡¹ç ”ç©¶ä¸­ï¼Œæˆ‘ä»¬ç¡®å®šäº†å››è·¨è›‹ç™½ 13 ï¼ˆTSPAN13ï¼‰ åœ¨è°ƒèŠ‚è‚¿ç˜¤ç»†èƒè¡¨é¢ä¸»è¦ç»„ç»‡ç›¸å®¹æ€§å¤åˆç‰© I ç±» ï¼ˆMHC-Iï¼‰ è¡¨è¾¾ä¸­çš„ä½œç”¨ï¼Œè¿™æ˜¯ CD8+ T ç»†èƒè¯†åˆ«è‚¿ç˜¤ç‰¹å¼‚æ€§æŠ—åŸæ‰€å¿…éœ€çš„ã€‚åœ¨ä¹³è…ºç™Œæ‚£è€…æ ·æœ¬ä¸­ï¼ŒTSPAN13 è¡¨è¾¾ä¸ CD8âº T ç»†èƒæµ¸æ¶¦å‘ˆè´Ÿç›¸å…³ã€‚åœ¨æœºåˆ¶ä¸Šï¼ŒTSPAN13 é€šè¿‡å‹Ÿé›† STUB1 å¢å¼º MHC-I çš„æ³›ç´ åŒ–ï¼Œä»è€Œä¿ƒè¿›æº¶é…¶ä½“é™è§£ï¼Œæ˜¾è‘—é™ä½ç»†èƒè¡¨é¢ MHC-I æ°´å¹³ã€‚ä½“å¤–å’Œä½“å†…å®éªŒéƒ½è¡¨æ˜ï¼Œè‚¿ç˜¤ç»†èƒä¸­ TSPAN13 çš„ä¸¢å¤±æ˜¾ç€å¢å¼ºäº† CD8+ T ç»†èƒæ´»æ€§å¹¶æ”¹å–„äº†å¯¹è‚¿ç˜¤ç»†èƒçš„ç»†èƒæ¯’æ€§ã€‚æ­¤å¤–ï¼ŒæŠ‘åˆ¶ TSPAN13 è¡¨è¾¾æ˜¾ç€å¢åŠ äº†è‚¿ç˜¤å¯¹æŠ— PD-L1</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1988725015225413632/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> <strong>åœ¨é€ è¡€ TET2 å¤±æ´»çš„æƒ…å†µä¸‹ï¼Œå¯¹å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­çš„ååº”å¢å¼º</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ä½¿ TET2 å¤±æ´»çš„ä½“ç»†èƒçªå˜æ˜¯å…‹éš†é€ è¡€ ï¼ˆCHï¼‰ æœ€å¸¸è§çš„é©±åŠ¨å› ç´ ä¹‹ä¸€ã€‚TET2 å¤±æ´»ä¸å•æ ¸ç»†èƒè¡ç”Ÿç‚ç—‡å’Œæ”¹å–„åµŒåˆæŠ—åŸå—ä½“ T ç»†èƒåŠŸèƒ½æœ‰å…³ï¼Œè¡¨æ˜å®ƒä¹Ÿå¯èƒ½å½±å“å…ç–«æ²»ç–—ååº”ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬å‘ç°å°é¼ æ¨¡å‹ä¸­çš„é€ è¡€ Tet2 çªå˜å¢å¼ºäº†å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­ ï¼ˆICBï¼‰ ååº”ï¼Œè¿™éœ€è¦åå™¬ç»†èƒã€CD4+ å’Œ CD8+ T ç»†èƒçš„è”åˆå­˜åœ¨ã€‚éšç€éª¨é«“æˆ– T ç»†èƒé™åˆ¶æ€§ Tet2 å¤±æ´»æˆ– 20% Tet2 çªå˜é€ è¡€çš„å°é¼ ï¼Œè¿™ç§æ•ˆæœä¼šæ¶ˆå¤±ã€‚ä»æœºåˆ¶ä¸Šè®²ï¼Œåœ¨ Tet2 çªå˜è‚¿ç˜¤æµ¸æ¶¦ç™½ç»†èƒ ï¼ˆTILï¼‰ ä¸­ï¼ŒICB ä¼˜å…ˆé™åˆ¶ä¸è‚¿ç˜¤è¿›å±•ç›¸å…³çš„ç»†èƒçŠ¶æ€ï¼ŒåŒæ—¶è¯±å¯¼æŠ—è‚¿ç˜¤çŠ¶æ€ã€‚Tet2 çªå˜å•æ ¸ç»†èƒæ¿€æ´»å…±åˆºæ¿€ç¨‹åºï¼Œè€Œ Tet2 çªå˜ T ç»†èƒè¡¨ç°å‡ºå¢å¼ºçš„ T ç»†èƒè®°å¿†ç‰¹å¾ï¼ŒåŒæ—¶å‡å°‘ç–²æƒ«å’Œè°ƒèŠ‚è¡¨å‹ã€‚ä¸´åºŠä¸Šï¼Œç»“ç›´è‚ ç™Œå’Œé»‘è‰²ç´ ç˜¤æ‚£è€…çš„ TET2 é©±åŠ¨çªå˜-CHï¼ˆTET2-CHï¼‰çš„è‚¿ç˜¤è¡¨ç°å‡ºå¢å¼ºçš„å…ç–«æµ¸æ¶¦ã€ç‚ç—‡å’Œ T ç»†èƒæ´»åŒ–ã€‚åœ¨æ¥å— ICB</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1988725040726781952/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> <strong>æ¢ç´¢ EGFR çªå˜ NSCLC ä¸­ EGFR TKI è€è¯çš„å‰æ™¯ - æœºåˆ¶å’Œä¸æ–­å‘å±•çš„æ²»ç–—æ–¹æ³•ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè€è¯</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: å¯¹ EGFR é…ªæ°¨é…¸æ¿€é…¶æŠ‘åˆ¶å‰‚ï¼ˆTKIsï¼‰çš„è€è¯æ€§ä»ç„¶æ˜¯ EGFR çªå˜éå°ç»†èƒè‚ºç™Œï¼ˆNSCLCï¼‰ä¸´åºŠæ²»ç–—çš„ä¸»è¦éšœç¢ã€‚å°½ç®¡ EGFR TKI çš„å¤šæ¬¡è¿­ä»£å…·æœ‰å˜é©æ€§çš„æ²»ç–—æ´»æ€§ï¼Œä»å„æ´›æ›¿å°¼å’Œå‰éæ›¿å°¼ç­‰ç¬¬ä¸€ä»£å¯é€†æŠ‘åˆ¶å‰‚åˆ°ç›®å‰æ ‡å‡†æŠ¤ç†çš„ç¬¬ä¸‰ä»£å…±ä»·æŠ‘åˆ¶å‰‚å¥¥å¸Œæ›¿å°¼ï¼Œä½†å¯¹è¿™äº›è¯ç‰©çš„åŸå‘æ€§æˆ–è·å¾—æ€§è€è¯æ€§ä¸å¯é¿å…åœ°é€šè¿‡ä¸åŒçš„æœºåˆ¶å‡ºç°ã€‚ç»“åˆåŒ–ç–—ã€æŠ—è¡€ç®¡ç”Ÿæˆå‰‚ã€åŒç‰¹å¼‚æ€§æŠ—ä½“æˆ–æŠ—ä½“-è¯ç‰©å¶è”ç‰©çš„è”åˆç–—æ³•çš„å‡ºç°å¢åŠ äº†ä¸´åºŠè·ç›Šï¼Œä½†å¼•å…¥äº†æ–°çš„è€è¯è¡¨å‹ï¼Œå¼ºè°ƒäº†æ²»ç–—å‹åŠ›ä¸‹è‚¿ç˜¤è¿›åŒ–çš„åŠ¨æ€å¯å¡‘æ€§å’Œå¤æ‚æ€§ã€‚åœ¨æœ¬ç»¼è¿°ä¸­ï¼Œæˆ‘ä»¬å…¨é¢ç»¼åˆäº†å¯¹ç¬¬ä¸‰ä»£ EGFR TKIs è€è¯çš„åˆ†å­æœºåˆ¶ï¼Œæè¿°äº†ç”Ÿç‰©æ ‡å¿—ç‰©å¼•å¯¼å’Œç”Ÿç‰©æ ‡å¿—ç‰©éé€‰æ‹©çš„æ²»ç–—ç­–ç•¥æ¥å…‹æœè¿™äº›æœºåˆ¶ï¼Œå¹¶è®¨è®ºäº†é€šè¿‡æ—©æœŸåº”ç”¨è”åˆç–—æ³•æ¥é¢„é˜²è€è¯æ€§çš„æ–°æ–¹æ³•ã€‚æˆ‘ä»¬å¼ºè°ƒäº†æ²»ç–—è€è¯æ€§ä»æ”¾å°„å­¦ç›‘æµ‹åˆ°åˆ†å­ç›‘æµ‹çš„èŒƒå¼è½¬å˜ï¼Œå¹¶æ¢è®¨äº†å¾ªç¯è‚¿ç˜¤ DNA åˆ†æã€äººå·¥æ™ºèƒ½å’Œå¤šç»„å­¦çš„è¿›æ­¥å¦‚ä½•ä¿ƒè¿›é€‚åº”æ€§æ²»ç–—ç­–ç•¥ã€‚éšç€æ²»ç–—æ ¼</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1988726423458787328/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>ç™Œç—‡ä¸­çš„ä¸­æ€§ç²’ç»†èƒç»†èƒå¤–é™·é˜±</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext:</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1988832524158218240/t>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (4æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨4æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨4æ¡ï¼‰</h4><p><strong>1.</strong> <strong>CellWhispererâ€”â€”å¤šæ¨¡æ€å­¦ä¹ æ”¯æŒåŸºäºèŠå¤©æ–¹å¼çš„å•ç»†èƒæ•°æ®æ¢ç´¢</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle-cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šCellWhisperer uses AI and RNA sequencing data to let researchers explore single-cell gene expression through natural-language chats, making complex biological data easier to understand and analyze&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/cellwhisperer-multimodal-learning-enables-chat-based-exploration-of-single-cell-data/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>åŸºäºç”Ÿç‰©å­¦ã€DNA/RNA å’Œäººå·¥æ™ºèƒ½çš„ä¸ªæ€§åŒ–ç™Œç—‡è¯Šæ–­ç»“æœï¼Œå¹³å‡ 10 å¤©å†…å³å¯äº¤ä»˜ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šFirst Ascent Biomedical integrates functional drug testing, RNA sequencing, and AI to deliver personalized cancer treatment insights in just ten days, helping oncologists act before cancer progresses&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/personalized-cancer-insights-grounded-in-biology-dna-rna-ai-delivered-in-an-average-of-10-days/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>Wegovy å’Œ Ozempic ä¸ç™Œç—‡æ­»äº¡ç‡å¤§å¹…ä¸‹é™æœ‰å…³</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šGLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study. Patients on the medications had less than half the mortality rate of non-users. Researchers suspect the drugsâ€™ anti-inflammatory and metabolic effects contribute to improved outcomes. Theyâ€™re now calling for clinical trials to test whether these findings reflect a true anti-cancer mechanism.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2025/11/251112011810.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>æ™ºèƒ½è¯ç‰©é¶å‘ç™Œç»†èƒä¸­éšè—çš„RNAå¼±ç‚¹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šResearchers have designed a smart drug that hunts down and breaks a little-known RNA that cancer cells depend on. The drug recognizes a unique fold in the RNA and triggers the cell to destroy it. Tests showed that removing this RNA slows cancer growth. The approach could lead to new treatments that attack cancer at its most fundamental level.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2025/11/251112111033.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>å…ç–«</td><td>11</td></tr><tr><td>å•ç»†èƒ</td><td>10</td></tr><tr><td>cancer</td><td>10</td></tr><tr><td>ç”Ÿä¿¡</td><td>9</td></tr><tr><td>è‚¿ç˜¤</td><td>8</td></tr><tr><td>é€šè·¯</td><td>5</td></tr><tr><td>ç¥ç»</td><td>5</td></tr><tr><td>leukemia</td><td>5</td></tr><tr><td>RNA-seq</td><td>4</td></tr><tr><td>ç™Œç—‡</td><td>4</td></tr><tr><td>resistance</td><td>4</td></tr><tr><td>sequencing</td><td>3</td></tr><tr><td>ChIP-seq</td><td>3</td></tr><tr><td>ç©ºé—´ç»„å­¦</td><td>3</td></tr><tr><td>methylation</td><td>3</td></tr><tr><td>ä»£è°¢</td><td>2</td></tr><tr><td>åŸºå› ç»„</td><td>2</td></tr><tr><td>æµ‹åº</td><td>2</td></tr><tr><td>single-cell</td><td>2</td></tr><tr><td>immune</td><td>2</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-å…¬ä¼—å·></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (28æ¡)</summary><div class=details-content markdown=1><ul><li><a href="https://mp.weixin.qq.com/s?__biz=MzI5ODI0NzM2OQ==&amp;mid=2247491574&amp;idx=1&amp;sn=e12a8543d86765ac6cb47fa10cf3c456">ä»é›¶å¼€å§‹å­¦ä¹ å•ç»†èƒå…ç–«ç»„åº“ï¼ˆä¸€ï¼‰ï¼šåŸºç¡€æ¦‚å¿µè½»æ¾æ˜æ™°ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247507103&amp;idx=2&amp;sn=5a8929fc6672e7ac9f87973846fa1fbb">æ–‡çŒ®åˆ†äº« | ã€Natureé‡ç£…å‘å¸ƒã€‘ç©ºé—´ä¸‰ç»„å­¦å…¨æ™¯å¼ç»˜åˆ¶å¤§è„‘å‘è‚²ä¸ç¥ç»ç‚ç—‡åŠ¨æ€å›¾è°±</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2NTE1MzU4NQ==&amp;mid=2247523404&amp;idx=1&amp;sn=648e40253e672bd1f6645458422a1e6e">ç”¨ R è¯­è¨€ç©è½¬è‚¿ç˜¤è€è¯é¢„æµ‹ï¼šä»æ•°æ®åˆ°æ¨¡å‹ï¼Œä¸€ç¯‡æå®šï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkxOTI0Mjc3Mw==&amp;mid=2247496703&amp;idx=1&amp;sn=de3d9310d2c963f71f7eb1aecbe476e7">ä»£è°¢ç‰©å¯¹å·¨å™¬ç»†èƒæåŒ–åŠè‚¿ç˜¤çš„å½±å“</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU1MDk1NTY5MA==&amp;mid=2247540954&amp;idx=1&amp;sn=2e7251ed3cd9b8ac3f0c69dae7e52b84">çº¿ä¸Šè®²åº§é¢„å‘Š | é¡¶åˆŠæ€ç»´Â·å‰æ²¿æ´è§â€”â€”å•ç»†èƒä¸ç©ºé—´ç»„å­¦åœ¨åŒ»å­¦åŠæ¤ç‰©ç ”ç©¶ä¸­çš„åˆ›æ–°åº”ç”¨</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247533627&amp;idx=1&amp;sn=b792c36ae5dd857f6bceece37e6ad69c">å•ç»†èƒå¤šç»„å­¦åˆ†æAIPèƒ°è…ºç‚æ‚£è€…å¹´é¾„ç›¸å…³Bç»†èƒï¼ˆABCï¼‰å…‹éš†æ‰©å¢ç‰¹å¼‚æ€§</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkwMjYyMDA1OA==&amp;mid=2247489214&amp;idx=1&amp;sn=70e72a1a94533041ad7695ee26368d1d">å…ç–«ç»„åº“åˆ†æå­¦ä¹ -Tç»†èƒå—ä½“(ä¸€ï¼‰</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzYyNDMwNjg3Nw==&amp;mid=2247484034&amp;idx=1&amp;sn=f02a67cbbaefb9c59d9d770dfa0e3892">è¯¦è§£ï¼šè‚ é“-è‚è„è½´çš„ä»£è°¢è°ƒæ§æœºåˆ¶</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkyMTI1MTYxNA==&amp;mid=2247519777&amp;idx=1&amp;sn=1216b2124d39fa48cd26393bc18e9279">å¯¼å¸ˆè®©æˆ‘åšä¸ªå•ç»†èƒè¯¾é¢˜ï¼Œæˆ‘ç›´æ¥æ‹’äº†</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503959&amp;idx=8&amp;sn=c7f13672c884d03e40e133498b3e04d3">åˆšåˆšå‘è¡¨çš„14+ç”Ÿä¿¡åˆ†æï¼Œè¯†åˆ«MMP11+æˆçº¤ç»´ç»†èƒè¿›è¡Œåˆ†æå’ŒéªŒè¯ï¼Œæœ¬æ–‡æ€è·¯æ–°é¢–ï¼Œå€¼å¾—è®¤çœŸå­¦ä¹ æ¨¡ä»¿ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503959&amp;idx=4&amp;sn=0fdcf03d6048c404051b88c95de509cb">ä»‹ç»ä¸¤ä¸ªç”Ÿä¿¡çƒ­ç‚¹å‘æ–‡æ€è·¯</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkwMzY2NjkwNg==&amp;mid=2247495530&amp;idx=1&amp;sn=d6558e06f00a4b5f544f095b7d23e14b">Nat Biotechnol |å¤©å‘ï¼Œä»»ä½•å’ŒAIæŒ‚é’©çš„éƒ½æ˜¯ç‹ç‚¸ï¼Œä»¥åå•ç»†èƒæœ€éš¾çš„è§£é‡Šéƒ¨åˆ†ï¼Œè¿˜æœ‰å•¥éš¾çš„</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkyNzcxMjEyMg==&amp;mid=2247497913&amp;idx=1&amp;sn=c3059ac4769547f4ff1ba47690e8598c">IF:5.7ï¼ŒæˆåŒ»å¤§è¿™ã€èŒç¾¤-è‚ -è„‘è½´+TLR4/NF-ÎºBé€šè·¯ã€‘æ€è·¯ï¼Œå°±æ˜¯å…¸å‹çš„æ ‡ä¹¦æ¨¡æ¿</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzI4ODc5MDI5NA==&amp;mid=2247503469&amp;idx=1&amp;sn=d3e0dd971776f7825a7e6cc4baf80688">ã€Šç™Œç»†èƒã€‹ï¼šåè½¬äº†ï¼ç§‘å­¦å®¶é¦–æ¬¡å‘ç°ï¼Œä¿ƒç™Œçš„TET2çªå˜å…‹éš†é€ è¡€ï¼Œç«Ÿä¼šä¿ƒè¿›å·¨å™¬ç»†èƒå‘ˆé€’æŠ—åŸï¼Œå¢å¼ºå…ç–«æ²»ç–—æ•ˆæœ</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkzNzY2NDgyOQ==&amp;mid=2247493289&amp;idx=1&amp;sn=12b6bf67a17eb960ee84a0c35dda040f">å‘å±•è½¨è¿¹çš„å½¢çŠ¶ï¼šç®€å•çš„å¤šé¡¹å¼æ›²çº¿-é€æ­¥å¼•å…¥å®Œå…¨éçº¿æ€§çš„è¶‹åŠ¿å»ºæ¨¡</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247546918&amp;idx=1&amp;sn=44e912011085ca09ab9f929f0cf393b1">scATAC-seqä¸­å¸¸è§çš„è´¨æ§å›¾</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247507103&amp;idx=1&amp;sn=d2da71f4a5c1e8e8f7f315e9f1ec5dc1">AlphaDIAï¼šæ‰“é€šDIAè›‹ç™½è´¨ç»„å­¦åˆ†æçš„â€œä»»ç£äºŒè„‰â€</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248461&amp;idx=7&amp;sn=186a8b8e7feb5ffba57e91c7f6050ccb">ç™»æƒå¨æœŸåˆŠï¼èšç„¦é£Ÿç®¡é³ç™Œç ”ç©¶ï¼šä¸­å›½åŒ»å­¦ç§‘å­¦é™¢è‚¿ç˜¤åŒ»é™¢å›¢é˜Ÿå‘ç°Notchä¿¡å·ä¿ƒè¡€ç®¡ç”Ÿæˆå…³é”®æœºåˆ¶</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248461&amp;idx=6&amp;sn=984c1d9fa00b52cf5bc6691c51957f8a">è™šæ‹Ÿæ„ŸæŸ“èƒ½è§¦å‘å…ç–«ååº”ï¼Ÿã€Šnature neuroscienceã€‹æ­ç¤ºå¤§è„‘çš„ç¥å¥‡é˜²å¾¡æœºåˆ¶</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248461&amp;idx=5&amp;sn=e3f8967a46a6bd1e8cdf29ff08f8e850">åˆ©ç”¨ç”Ÿå­˜é¢„åæ¨¡å‹é¢„æµ‹ç™Œç—‡æ‚£è€…ç»“å±€ï¼šä»æ•°æ®åˆ†æåˆ°æ¨¡å‹è§£è¯»</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248461&amp;idx=4&amp;sn=ac2032ec8e6c7a783b2fd8c1ff84d739">é¡¶åˆŠæŒç»­å‘åŠ›ï¼Œæ¢ç´¢å¤§è„‘ç¨³æ€çš„å¥¥ç§˜ï¼šå°èƒ¶è´¨ç»†èƒä¸ç¥ç»å…ƒçš„å¯¹è¯</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248461&amp;idx=2&amp;sn=977cc06e7914514e6636017e1e914919">ç™»é¡¶topçº§æœŸåˆŠï¼GWAS+å•ç»†èƒåˆ†æè§£å¯†ç–¾ç—…æœºåˆ¶ï¼Œè¿™æ³¢æ€è·¯å¿…é¡»å­¦ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649935&amp;idx=6&amp;sn=fa8068580202375d595b040c45ed002a">Neuronï¼šä¸­å›½ç§‘å­¦é™¢è„‘æ™ºå“è¶Šä¸­å¿ƒæœä¹…æ—ç»„å‘ç°å¤§è„‘è¡€æµå…¨å±€è°ƒé…çš„ç¥ç»æœºåˆ¶</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649935&amp;idx=4&amp;sn=efa41dc81a39784174818204a32349ac">Cellï¼šæ›¹ç¿/è–›å¤©/é™ˆè´ºå›¢é˜Ÿé˜é‡Š 5-HT1A å—ä½“ä¿¡å·é€šè·¯é€‰æ‹©æ€§æœºåˆ¶å¹¶è®¾è®¡å‡ºæ–°å‹å¿«é€ŸæŠ—æŠ‘éƒè¯ç‰©åˆ†å­</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649935&amp;idx=3&amp;sn=769af18c80110f79a156ae1ec27886cd">Natureï¼šè¥¿æ¹–å¤§å­¦é‚¹è´»é¾™å›¢é˜Ÿåˆä½œå¼€å‘å¾®ç±³çº§è›‹ç™½è´¨ç»„å­¦æˆåƒæ–°æŠ€æœ¯</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649935&amp;idx=2&amp;sn=4f8b20d100756549306b3fc45961df1f">Nature åè¿˜æœ‰æ–°çªç ´ï¼Ÿæƒå¨æœŸåˆŠè¯¦è§£ç¥ç»ç–¾ç—…ç”Ÿç‰©æ ‡å¿—ç‰©ç ”ç©¶æ€è·¯</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247503133&amp;idx=1&amp;sn=6c3dbabebc2473ce6004529384fb11c7">å¤šç»„å­¦ | Nat.Genet. | åˆ©ç”¨å¤šç»„å­¦æ•°æ®é¢„æµ‹éå°ç»†èƒè‚ºç™Œå…ç–«æ²»ç–—æ•ˆæœçš„ç©ºé—´ç‰¹å¾</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkxODY4NDEwMA==&amp;mid=2247489832&amp;idx=1&amp;sn=076c4f1616c8ca1489a058ddcb8672e9">ç”·æ€§è¡°è€çš„æ ‡å¿—:1è‡­2é«˜3å¤§2å°</a></li></ul></div></details><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (25æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309417">GSE309417 å…”è½¯éª¨è†œç»„ç»‡çš„ RNA-seq åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301148">GSE301148 åŒæ—¶é¶å‘ KRAS å’Œ CDK4 å¯ååŒè¯±å¯¼èƒ°è…ºç™Œç»†èƒæŒä¹…ç”Ÿé•¿åœæ» [AsPC-1_RNA_Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301146">GSE301146 åŒæ—¶é¶å‘ KRAS å’Œ CDK4 å¯ååŒè¯±å¯¼èƒ°è…ºç™Œç»†èƒæŒä¹…ç”Ÿé•¿åœæ» [51T-2D_RNA_Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272333">GSE272333 æ„å»ºåŸºäºæ¿€å…‰æ•è·æ˜¾å¾®åˆ‡å‰²çš„äººç±»ç”Ÿé•¿æœŸæ¯›å›Šè½¬å½•ç»„å›¾è°±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248519">GSE248519 ZKSCAN3 é€šè¿‡ä¸Šè°ƒ HSPB1 ä¿ƒè¿›åµå·¢ç™Œç»†èƒå¢æ®–</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304997">GSE304997 CDK4/6æŠ‘åˆ¶é€šè¿‡Rbä¾èµ–æ€§æŸ“è‰²è´¨å’Œè½¬å½•ç»„é‡å¡‘é‡ç¼–ç¨‹ä¹³è…ºç™Œå…ç–«è‚½ç»„</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304675">GSE304675 é€†è½¬çš„äººç±»iPSCè¡ç”Ÿè‚æ˜ŸçŠ¶ç»†èƒå¼‚è´¨æ€§çš„å•ç»†èƒåˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293442">GSE293442 ä½“å¤–è¡ç”ŸNMPçš„Brachyury (T) ChIP-seqåˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291742">GSE291742 Sp8åœ¨åˆ†åŒ–å°é¼ èƒšèƒå¹²ç»†èƒä¸­çš„å…¨åŸºå› ç»„ç»“åˆè°±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287955">GSE287955 CDK4/6æŠ‘åˆ¶é€šè¿‡Rbä¾èµ–æ€§æŸ“è‰²è´¨å’Œè½¬å½•ç»„é‡å¡‘é‡ç¼–ç¨‹ä¹³è…ºç™Œå…ç–«è‚½ç»„</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE252659">GSE252659 å¯¹å¯¹ç…§ç»„å’Œ Sp5/8 åŒæ•²é™¤æˆ– Wnt3a æ•²é™¤èƒšèƒçš„ E8.25 åéƒ¨ç»„ç»‡ +2 ä½“èŠ‚è¿›è¡Œæ‰¹é‡ RNA æµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304892">GSE304892 p210æ¿€é…¶ç»“æ„åŸŸçªå˜æ£€æµ‹</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302709">GSE302709 ç”Ÿç‰©å·¥ç¨‹ç»†èƒå¤–å›Šæ³¡å…±é€’é€ PD-L1 å’Œ miR-27a-3p ååŒé‡ç¼–ç¨‹ T ç»†èƒä»¥æ²»ç–—ç‚ç—‡æ€§è‚ ç—… [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302696">GSE302696 ç”Ÿç‰©å·¥ç¨‹ç»†èƒå¤–å›Šæ³¡å…±é€’é€ PD-L1 å’Œ miR-27a-3p ååŒé‡ç¼–ç¨‹ T ç»†èƒä»¥æ²»ç–—ç‚ç—‡æ€§è‚ ç—… [scRNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280074">GSE280074 ä½“å†…DNAç”²åŸºåŒ–ç¼–è¾‘[WGBS]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250483">GSE250483 é€šè¿‡æ•´åˆçŸ­è¯»é•¿å’Œé•¿è¯»é•¿RNAæµ‹åºå‘ç°æ–°å‹ç¯çŠ¶RNA</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306484">GSE306484 åˆ©ç”¨ ReSisTrace è°±ç³»è¿½è¸ªæŠ€æœ¯æ­ç¤ºæ€¥æ€§é«“ç³»ç™½è¡€ç—…ä¸­å¯¹ FLT3 æŠ‘åˆ¶å‰‚çš„é¢„è‡´æ•å› å­</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298330">GSE298330 ArpC5çªå˜å°é¼ å’Œå¯¹ç…§å°é¼ å›è‚ å…ç–«ç»†èƒå•ç»†èƒæ°´å¹³çš„åŸºå› è¡¨è¾¾è°±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290177">GSE290177 çƒ­ä¼‘å…‹è½¬å½•å› å­ (HSF) ä»‹å¯¼æ¤ç‰©ä¸­çƒ­è¯±å¯¼æŸ“è‰²è´¨åŠ¨æ€çš„å¤šå±‚è°ƒæ§ [ATAC-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290176">GSE290176 çƒ­ä¼‘å…‹è½¬å½•å› å­ (HSF) ä»‹å¯¼æ¤ç‰©ä¸­çƒ­è¯±å¯¼æŸ“è‰²è´¨åŠ¨æ€çš„å¤šå±‚è°ƒæ§ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285103">åˆ©ç”¨ GSâ€‹â€‹E285103 CENH3-ChIP-seq å¯¹ Chamaelirium luteum è¿›è¡Œæµ‹åºï¼Œä»¥ç¡®å®šå…¶å¤§ç€ä¸ç²’çš„å¤§å°å’Œåºåˆ—ç»„æˆã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285102">åˆ©ç”¨GSE285102 ATAC-seqæµ‹åºæ•°æ®ï¼Œå¯¹é»„è¤æ‹Ÿå±‚å­”é›€è—»ï¼ˆChamaelirium luteumï¼‰è¿›è¡Œæµ‹åºï¼Œä»¥ç¡®å®šå…¶å¯åŠæŸ“è‰²è´¨åŒºåŸŸã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248682">GSE248682 æ–°ç”Ÿ RNA åˆ†ææ­ç¤ºäº†åŸºå› ç»„èŒƒå›´å†…çš„é«˜æ•ˆé‡å¤èµ·å§‹è°ƒæ§ç»†èŒåŸºå› è½¬å½•</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE247772">GSE247772 è‡´æ­»æ€§å·¨å‹å¹¼è™«åŸºå› å®¶æ—åœ¨çš®è‚¤è¡¨çš®ä¸­å‘æŒ¥æŠ‘ç™ŒåŸºå› çš„ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE239990">GSE239990 çœŸçš®è„‚è‚ªç»†èƒé€šè¿‡ä»£è°¢é€šè®¯æ¿€æ´»æ¯›å›Šå¹²ç»†èƒ</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-13 21:36</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week462025/ rel=tag>Week462025</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2025-11-13/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-13</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2025-11-15/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-15</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-08/>ç§‘ç ”æ—¥æŠ¥ 2026-02-08</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-07/>ç§‘ç ”æ—¥æŠ¥ 2026-02-07</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-06/>ç§‘ç ”æ—¥æŠ¥ 2026-02-06</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-05/>ç§‘ç ”æ—¥æŠ¥ 2026-02-05</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-04/>ç§‘ç ”æ—¥æŠ¥ 2026-02-04</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (101)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (101)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week052026/ title=Week052026>Week052026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week062026/ title=Week062026>Week062026 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>